acut
respiratori
distress
syndrom
ard
lifethreaten
noncardiogen
circulatori
disord
lung
associ
critic
ill
sepsi
trauma
immun
collagen
vascular
diseas
mortal
rate
margin
improv
best
support
care
demis
occur
due
progress
pulmonari
hypoxia
multiorgan
dysfunct
syndrom
mod
sever
inflamm
complement
activ
part
immun
respons
pathogen
insult
membran
attack
complex
mac
form
elimin
microb
complement
regulatori
protein
endotheli
underexpress
mac
may
also
caus
pulmonari
vascular
injuri
innoc
bystand
endotheli
cell
host
provok
endotheliopathi
caus
inflamm
pulmonari
vascular
microthrombosi
lead
ard
acut
respiratori
distress
syndrom
ard
caus
sever
pulmonari
vascular
dysfunct
character
acut
onset
dyspnea
tachycardia
hypoxemia
associ
noncardiogen
pulmonari
edema
system
inflamm
although
exact
pathophysiolog
mechan
caus
pulmonari
vascular
dysfunct
determin
yet
circulatori
dysfunct
often
associ
moder
thrombocytopenia
multiorgan
dysfunct
syndrom
mod
pathogenet
mechan
clearli
recogn
effect
therapeut
agent
target
underli
patholog
diseas
procur
date
ventil
support
fluid
electrolyt
balanc
cardiopulmonari
monitor
best
support
care
margin
improv
outcom
ard
sever
decad
mortal
rate
still
high
increas
diseas
sever
multicent
intern
prospect
cohort
studi
patient
ard
unadjust
hospit
mortal
report
among
mild
ard
moder
diseas
patient
sever
ard
recent
two
propos
hemostat
mechan
open
door
understand
ard
molecular
pathogenesi
associ
endotheliopathi
promot
inflamm
coagul
disord
sepsi
critic
ill
one
twoactiv
theori
endothelium
endotheli
pathogenesi
activ
inflammatori
pathway
microthrombot
pathway
novel
twopath
unifi
theori
hemostasi
hemostasi
initi
thrombogenesi
promot
microthrombogenesi
lead
vascular
microthrombot
diseas
vmtd
two
theori
congruou
sinc
endothelium
contribut
initi
hemostasi
trigger
molecular
mechan
thrombogenesi
endotheliopathi
patholog
natur
inflamm
promot
inflammatori
respons
recogn
charact
microthrombi
lead
multipl
hematolog
phenotyp
identifi
addit
true
mechan
vivo
hemostasi
vascular
injuri
three
differ
thrombogenet
mechan
within
hemostasi
uncov
recognit
endotheli
molecular
pathogenesi
enough
evid
accumul
ard
one
phenotyp
mod
occur
result
dissemin
intravascular
microthrombosi
dit
underli
patholog
contribut
endotheliopathyassoci
vmtd
eavmtd
object
articl
analyz
clinic
patholog
hematopatholog
featur
ard
account
involv
pathophysiolog
mechan
associ
endotheli
dysfunct
base
two
hemostat
theori
end
author
look
potenti
therapeut
option
treatment
ard
accord
theorybas
medicin
instead
evidencebas
medicin
sinc
clinic
trial
ard
complet
fail
find
effect
therapeut
regimen
common
underli
condit
ard
sever
infect
eg
sepsissept
shock
without
sever
pneumonia
due
variou
microb
pathogen
includ
bacteria
virus
fungi
rickettsia
parasit
ard
also
occur
associ
trauma
chestlung
headbrain
complic
surgeri
pregnanc
transplant
certain
drug
toxin
chemic
venom
exposur
thrombot
thrombocytopen
purpura
ttp
like
syndrom
addit
also
develop
associ
dissemin
intravascular
coagul
dic
clinician
interpret
dic
caus
ard
other
propos
result
complic
ard
regardless
enough
evid
present
ard
clinic
disord
patholog
hemostasi
associ
activ
coagul
system
dic
howev
author
place
quotat
mark
dic
recent
reinterpret
identifi
current
concept
dic
illfound
base
hemostat
mechan
activ
tissu
factor
tf
path
discuss
briefli
later
articl
nonetheless
ard
one
major
organ
phenotyp
disord
among
mod
contribut
death
associ
microthrombosi
critic
ill
patient
due
diseas
sepsi
trauma
immun
disord
shown
tabl
although
ard
often
occur
associ
varieti
sepsi
preced
pneumonia
seen
sever
respiratori
distress
syndrom
sar
due
sarscov
middl
east
respiratori
syndrom
mer
due
merscov
well
bacteri
fungal
parasit
pneumonia
especi
pneumococc
particular
clinic
featur
develop
pneumonia
sepsi
suggest
organotrop
play
import
role
certain
pathogen
shown
sar
viru
possess
specif
affin
lung
sometim
ard
occur
follow
blood
transfus
call
transfusionrel
acut
lung
injuri
trali
character
acut
noncardiogen
circulatori
disord
lung
follow
blood
product
transfus
sepsisassoci
ard
notwithstand
absenc
pneumonia
uncommonli
develop
organ
dysfunct
encephalopathi
hepat
failur
acut
renal
failur
acut
necrot
pancreat
multiorgan
involv
suggest
ard
may
primari
diseas
like
part
ongo
system
pathogenet
mechan
due
infect
critic
ill
illustr
tabl
underli
physiolog
alter
mod
sepsi
critic
ill
identifi
circulatori
dysfunct
occur
result
eavmtd
extrem
import
concept
understand
pathogenesi
mod
well
ard
know
culprit
mod
dit
pathogenesi
base
twoactiv
theori
endothelium
shown
figur
clinic
patholog
featur
clinic
featur
ard
character
acut
onset
noncardiogen
respiratori
distress
bilater
pulmonari
infiltr
evid
diffus
circulatori
obstruct
pulmonari
vasculatur
addit
acut
respiratori
distress
hematolog
featur
ard
includ
thrombocytopenia
mod
dit
dic
ttplike
syndrom
present
tabl
manifest
seem
consist
hemostat
disord
recogn
eavmtd
recent
debat
whether
ard
caus
thrombocytopenia
inflamm
mod
dic
rather
result
anoth
patholog
condit
produc
hematolog
phenotyp
later
discuss
dilemma
explor
pathophysiolog
mechan
ard
establish
patholog
featur
ard
character
diffus
alveolar
damag
associ
injuri
alveolar
line
endotheli
cell
ec
exud
pulmonari
edema
hyalin
membran
format
patholog
chang
similar
ident
ard
caus
differ
pathogen
insult
includ
pneumoniainiti
sar
mer
one
uniqu
abnorm
hyalin
membran
formationdeposit
patholog
featur
appear
similar
vmtd
associ
ttp
ttplike
syndrom
microthrombi
character
hyalin
thrombi
compos
unusu
larg
von
willebrand
factor
multim
ulvwf
platelet
even
though
ard
develop
associ
diverg
etiolog
sepsi
envenom
patholog
clinic
featur
remark
similar
among
differ
underli
diseas
diffus
alveolar
damag
histolog
chang
patient
ard
progress
includ
phase
exud
prolif
fibrot
chang
correl
time
rather
specif
caus
find
consist
hypothesi
pathogenesi
ard
due
multifactori
process
primarili
involv
lung
result
one
pathophysiolog
mechan
affect
lung
multiorgan
consumpt
thrombocytopenia
critic
ill
patient
critic
ill
thrombocytopenia
commonli
occur
ard
cours
diseas
even
known
caus
thrombocytopenia
heparininduc
thrombocytopenia
transfus
drugrel
thrombocytopenia
bone
marrow
suppress
identifi
thrombocytopenia
exclud
mechan
undetermin
thrombocytopenia
clearli
account
case
thu
design
thrombocytopenia
critic
ill
patient
tcip
recent
critic
ill
sepsi
trauma
thrombocytopenia
suspect
associ
endotheliopathi
initi
microthrombogenesi
form
microthrombi
platelet
consumpt
occur
ulvwf
releas
endotheliopathi
recruit
platelet
form
plateletulvwf
complex
becom
microthrombi
string
platelet
consum
concept
tcip
direct
unequivoc
evid
endotheliopathi
promot
vivo
hemostasi
thrombocytopenia
critic
ill
patient
usual
present
mild
moder
decreas
platelet
count
bleed
signific
issu
care
critic
ill
patient
accord
hemostat
principl
tabl
blood
vessel
damag
limit
ec
endotheliopathi
figur
endotheli
molecular
pathogenesi
ard
mod
critic
ill
patient
base
twoactiv
theori
endothelium
reproduc
modifi
chang
endotheli
molecular
pathogenesi
ard
one
organ
phenotyp
among
variou
mod
succinctli
illustr
underli
patholog
natur
ard
hemostat
diseas
due
endotheliopathi
promot
activ
two
molecular
pathway
one
inflammatori
pathway
releas
cytokin
provok
inflamm
includ
fever
malais
myalgia
microthrombot
pathway
caus
exocytosi
ulvwf
platelet
activ
trigger
much
deadli
dit
via
microthrombogenesi
lead
eavmtddit
dissemin
intravascular
thrombosi
orchestr
consumpt
thrombocytopenia
maha
mod
ttplike
syndrom
ard
indic
acut
respiratori
distress
syndrom
dit
dissemin
intravascular
thrombosi
eavmtd
endotheliopathyassoci
vascular
microthrombot
diseas
ec
endotheli
cell
hc
hepat
coagulopathi
mahaamaha
microangiopath
hemolyt
anemiaatyp
microangiopath
hemolyt
anemia
mod
multiorgan
dysfunct
syndrom
mof
multiorgan
failur
tma
thrombot
microangiopathi
sir
system
inflammatori
respons
syndrom
ttp
thrombot
thrombocytopen
purpura
ulvwf
unusu
larg
von
willebrand
factor
multim
activ
ulvwf
path
tf
path
activ
subendotheli
tissu
set
extravascular
tissu
evt
illustr
figur
compromis
hemostat
natur
microthrombosi
associ
critic
ill
recogn
date
tcip
benignli
neglect
although
bone
et
al
late
observ
thrombocytopenia
signific
compon
describ
thrombocytopenia
ard
tcip
found
consumpt
thrombocytopenia
caus
microthrombogenesi
lead
eavmtddit
recent
signific
role
platelet
recogn
care
patient
critic
ill
ard
degre
thrombocytopenia
sepsi
associ
increas
sever
higher
mortal
thrombocytopenia
increas
risk
predict
patient
mortal
ard
thrombot
thrombocytopen
purpuralik
syndrom
mild
moder
thrombocytopenia
present
ard
author
often
found
mask
microangiopath
hemolyt
anemia
maha
hematolog
evalu
microangiopath
hemolyt
anemia
less
promin
ard
fewer
schistiocyt
acquir
immun
ttp
also
mild
moder
anemia
howev
evid
hemolysi
evid
reticulocytosi
hypohaptoglobinemia
increas
lactic
acid
dehydrogenas
indirect
hyperbilirubinemia
call
atyp
maha
common
ttplike
syndrom
ie
eavmtd
literatur
case
report
describ
associ
ard
ttplike
syndrom
author
experi
ard
coexist
ttplike
syndrom
respond
dramat
therapeut
plasma
exchang
tpe
employ
earli
stage
ard
reason
diagnosi
ttplike
syndrom
mask
ard
due
inconspicu
schistocytosi
unsuspect
diagnosi
well
major
attent
patient
care
direct
respiratori
distress
realtim
clinic
practic
like
also
due
diametr
differ
pathogenes
ttp
ttplike
syndrom
clear
distinct
recogn
recent
also
caus
fact
ard
never
consid
hemostat
diseas
ttplike
syndrom
unknown
caus
endotheliopathi
tabl
three
essenti
normal
hemostasi
hemostat
principl
hemostasi
activ
vascular
injuri
hemostasi
must
activ
ulvwf
path
andor
tf
path
hemostasi
process
hemorrhag
thrombosi
hemostasi
process
arteri
thrombosi
venou
thrombosi
clinic
medicin
patient
ard
evalu
high
index
suspicion
look
atyp
maha
well
thrombocytopenia
unexplain
thrombocytopenia
firm
evid
hemolysi
even
minim
schistocyt
repeat
blood
film
examin
may
still
consist
ttplike
syndrom
multiorgan
dysfunct
syndrom
late
vesconi
et
al
suspect
ard
caus
pulmonari
vascular
microthrombosi
follow
eleg
investig
demonstr
pulmonari
microvascular
occlus
lesion
balloon
occlus
pulmonari
angiographi
patient
sever
adult
respiratori
distress
studi
multipl
pulmonari
arteri
fill
defect
detect
find
interpret
consist
vascular
microthrombosi
howev
concept
microthrombosi
defin
yet
coagul
commun
nonetheless
thesi
microvascular
thrombosi
vascular
microthrombosi
explain
compromis
vascular
circulatori
function
lung
occlus
lesion
pulmonari
angiographi
better
proposit
propos
theori
pathogenesi
ard
includ
pulmonari
vascular
endotheli
injuri
lead
endotheli
dysfunct
due
inflammatori
cytokin
activ
immun
cell
upregul
adhes
molecul
solubl
vascular
adhes
molecul
eselectin
underexpress
vascular
endotheli
cadherin
interact
neutrophil
cytokin
promot
transendotheli
migrat
cytokineprim
neutrophil
neutrophil
extracellular
trap
net
provok
coagul
microcirculatori
failur
howev
theori
could
defin
molecular
chang
occur
lead
ard
produc
increas
capillari
permeabl
consid
hallmark
ard
importantli
theori
answer
inflamm
ard
frequent
associ
simultan
hematolog
syndrom
mod
proposit
microthrombosi
import
thesi
first
time
potenti
hemostat
natur
ard
suggest
vascular
microthrombosi
microvascular
thrombosi
well
recogn
underli
diseas
ttp
recent
ttplike
syndrom
occur
eavmtd
well
dic
although
molecular
mechan
ard
remain
elus
later
khadaroo
marshal
correctli
understood
vascular
microthrombosi
could
contribut
clinic
express
ard
lung
also
mod
vital
organ
addit
common
associ
ard
mod
similar
pulmonari
patholog
chang
differ
pathogen
noninfecti
critic
ill
support
mechan
clinic
figur
schemat
illustr
cross
section
blood
vessel
histolog
hemostat
compon
blood
vessel
wall
site
hemostasi
coagul
produc
hemostat
plug
vascular
injuri
stop
hemorrhag
extern
vascular
injuri
also
site
hemostasi
thrombogenesi
produc
intravascular
blood
clot
intravascular
injuri
caus
thrombosi
histolog
compon
divid
endothelium
tunica
intima
tunica
media
tunica
externa
compon
differ
function
contribut
molecular
hemostasi
shown
illustr
endotheli
injuri
trigger
exocytosi
ulvwf
ec
set
injuri
promot
releas
stf
tunica
intima
tunica
media
tunica
externa
evt
injuri
induc
releas
etf
outsid
blood
vessel
wall
depth
blood
vessel
injuri
contribut
genesi
differ
thrombot
disord
microthrombosi
macrothrombosi
fibrin
clot
diseasehematoma
concept
import
understand
endotheliopathi
lead
ard
lead
lone
activ
ulvwf
produc
microthrombi
string
ec
ard
indic
acut
respiratori
distress
syndrom
ec
endotheli
cell
etf
extravascular
tf
evt
extravascular
tissu
rbc
red
blood
cell
set
subendotheli
tissu
stf
subendotheli
tf
tf
tissu
factor
ulvwf
unusu
larg
von
willebrand
factor
multim
phenotyp
mod
occur
result
system
diseas
vmtd
display
figur
exampl
similar
organ
phenotyp
hemolyt
urem
syndrm
hu
kidney
organ
phenotyp
ard
lung
caus
microvascular
thrombosi
also
characterist
ttp
ttplike
syndrom
dic
thrombot
microangiopathi
context
conclud
ard
hu
everi
organ
syndrom
mod
also
manifest
eavmtddit
illustr
figur
elabor
figur
inde
ard
one
phenotyp
among
mod
associ
increas
microvascular
permeabl
due
vmtd
involv
multiorgan
also
true
current
biorgan
design
syndrom
hepatoren
syndrom
cardiopulmonari
syndrom
pulmonaryren
syndrom
hepat
encephalopathi
cardioren
syndrom
other
emphas
ard
caus
mod
organ
phenotyp
mod
well
ard
collater
syndrom
provok
vmtd
next
import
question
clinic
express
vmtd
variabl
develop
mod
among
everi
individu
patient
shown
figur
discuss
head
tropism
endotheli
heterogen
within
pathophysiolog
mechan
involv
ard
system
inflammatori
respons
syndrom
american
colleg
chest
physician
societi
critic
care
medicin
introduc
definit
system
inflammatori
respons
syndrom
sir
sepsi
sever
sepsi
septic
shock
mod
earli
idea
propos
term
sir
recogn
clinic
respons
nonspecif
insult
either
infecti
noninfecti
origin
howev
sir
could
nt
defin
diseas
entiti
thu
remain
complex
clinic
syndrom
associ
sepsi
noninfecti
critic
ill
pathogenesi
sir
clearli
establish
gener
consid
express
selfdefens
mechan
overwhelm
patholog
insult
past
decad
becom
evid
endotheliopathi
play
major
role
sepsi
inflamm
coagul
gener
endotheliopathi
sir
commonli
occur
associ
ard
manifest
combin
sever
inflamm
via
cytokin
releas
microthrombosi
via
microthrombogenesi
often
lead
mod
sever
ard
inflamm
coexist
pathogenesi
mod
seen
ard
summar
organ
involv
vmtd
associ
withwithout
ard
howev
mod
much
common
vital
organ
especi
lung
ard
brain
cnsd
kidney
acut
renal
failur
pleas
note
ard
shown
associ
everi
illustr
organ
syndrom
aai
indic
acut
adren
insuffici
alf
acut
liver
failur
anp
acut
necrot
pancreat
ard
acut
respiratori
distress
syndrom
arf
acut
renal
failur
cnsd
central
nervou
system
dysfunct
dit
dissemin
intravascular
microthrombosi
eavmdt
endotheliopathyassoci
vascular
microthrombot
diseas
fhf
fulmin
hepat
failur
hcp
hantaviru
cardiopulmonari
syndrom
hepat
encephalopathi
hp
hantaviru
pulmonari
syndrom
hr
hepatoren
syndrom
hu
hemolyt
urem
syndrom
mod
multiorgan
dysfunct
syndrom
nomi
nonocclus
mesenter
ischemia
pdi
peripher
digit
ischem
syndrom
rml
rhabdomyolysi
spg
symmetr
peripher
gangren
wf
waterhousefriderichsen
syndrom
organ
phenotyp
encephalopathi
acut
renal
failur
myocardi
infarct
pancreat
fulmin
hepat
failur
adren
insuffici
other
thu
sir
best
defin
combin
syndrom
sever
inflammatori
respons
activ
inflammatori
pathway
organ
dysfunct
activ
microthrombot
pathway
result
gener
system
endotheliopathi
howev
understand
inflamm
microthrombosi
endotheliopathi
two
separ
process
although
crosstalk
mechan
popular
molecular
pathogenes
independ
illustr
twoactiv
theori
endothelium
figur
reason
clinic
trial
base
antiinflammatori
regimen
impact
coagul
system
fail
improv
outcom
demonstr
manag
sepsisassoci
coagulopathi
clinic
practic
inflamm
alon
major
factor
caus
poor
outcom
patient
clinic
sever
mod
caus
vmtd
main
culprit
demis
sever
sepsi
dissemin
intravascular
coagul
dissemin
intravascular
coagul
occur
ard
without
sepsi
consid
seriou
coagulopathi
sepsi
also
human
diseas
estim
occur
patient
sepsi
studi
japan
found
diagnosi
dic
complic
admiss
univers
hospit
accord
nih
nation
heart
lung
blood
institut
dic
condit
blood
clot
form
throughout
bodi
small
blood
vessel
blood
clot
reduc
block
blood
flow
blood
vessel
damag
bodi
organ
gener
clinician
pathologist
defin
dic
widespread
hypercoagul
state
lead
microvascular
macrovascular
clot
compromis
blood
flow
ultim
result
multipl
organ
dysfunct
mod
truth
coagulopathi
dic
could
nt
precis
defin
concept
microthrombosi
thrombogenesi
identifi
yet
physiolog
mechan
vivo
hemostasi
incomplet
understood
exampl
role
von
willebrand
factor
vwf
thrombogenesi
coagul
also
role
platelet
coagul
cascad
differ
fibrin
clot
activ
tf
path
thrombosi
deep
vein
thrombosi
dvt
differ
microthrombi
macrothrombu
microthrombosi
dissemin
dvt
local
coagul
differ
thrombogenesi
question
seem
philosoph
one
urgent
need
practic
question
patient
care
simpl
answer
differ
dvt
dic
former
respond
anticoagul
latter
current
dilemma
dic
found
incorrect
charact
also
accept
contemporari
pathogenet
mechan
accord
author
interpret
reinterpret
dic
base
twopath
unifi
theori
hemostasi
mechan
thrombogenesi
clearli
support
occur
result
activ
ulvwf
path
credibl
dic
coagulopathi
blame
microthrombi
compos
plateletulvwf
complex
via
microthrombogenesi
fibrin
clot
made
fibrin
platelet
coagul
factor
uncontrol
activ
tfiniti
path
other
serious
undermin
irreconcil
conflict
microthrombi
fibrin
clot
vivo
hemostat
process
microthrombi
fibrin
clot
easili
differenti
illustr
figur
b
true
charact
blood
clot
dic
microthrombi
occur
vmtd
seen
ttp
ttplike
syndrom
also
pathophysiolog
mechan
dic
tffviia
complexactiv
coagul
cascad
instead
partial
hemostasi
due
lone
activ
ulvwf
path
sinc
dic
ie
microthrombosi
occur
result
endotheliopathi
alon
without
damag
setevt
tf
path
activ
author
deriv
two
theori
twoactiv
theori
endothelium
twopath
unifi
theori
hemostasi
analysi
interpret
patholog
clinic
laboratori
molecular
characterist
dic
ttplike
syndrom
elabor
hypothes
previou
public
therefor
shall
repeat
short
affirm
dic
exactli
eavmtddit
hematolog
phenotyp
ttplike
syndrom
sum
concept
dic
built
follow
faulti
pathophysiolog
mechan
hemostasi
comment
follow
statement
dic
uncontrol
tf
path
initi
coagul
disord
occur
sepsi
critic
ill
instead
ulvwf
path
initi
microthrombot
disord
dic
trigger
inflamm
lead
patholog
fibrin
clot
crosstalk
inflamm
coagul
instead
trigger
microthrombogenesi
lead
patholog
microthrombi
string
crosstalk
involv
dic
caus
microvascular
thrombosi
initi
tffviia
complex
instead
caus
vascular
microthrombosi
initi
plateletulvwf
complex
dic
consum
coagul
factor
platelet
clot
process
instead
result
releas
ulvwf
injur
ec
consum
platelet
format
microthrombi
string
acut
dic
character
thrombocytopenia
maha
mod
sever
hemorrhag
syndrom
figur
normal
hemostasi
base
twopath
unifi
theori
reproduc
updat
permiss
chang
normal
hemostasi
two
differ
thrombot
path
microthrombot
ulvwf
fibrinogenet
tf
involv
normal
hemostasi
later
path
must
unifi
conclud
normal
hemostasi
passiv
role
net
stop
bleed
extern
bodili
injuri
produc
thrombosi
intravascular
injuri
howev
differ
level
depth
intravascular
injuri
thrombogenesi
take
two
differ
path
level
intravascular
injuri
confin
endothelium
lone
ulvwf
path
becom
activ
caus
microthrombosi
ie
eavmtd
tf
path
activ
hand
level
intravascular
injuri
extend
endothelium
setevt
tf
path
becom
also
activ
caus
macrothrombosi
eg
dvt
anoth
theoret
situat
setevt
injur
avail
tf
suppos
activ
lone
tf
path
howev
patholog
hemostasi
aberr
tf
activ
occur
produc
fibrin
clot
ie
true
dic
apl
due
tf
express
intravascular
space
leukem
promyelocyt
acut
promyelocyt
leukemia
caus
consumpt
coagulopathi
due
lone
activ
tf
path
logic
base
twopath
unifi
theori
pleas
note
differ
thrombot
disord
via
microthrombogenesi
fibrinogenesi
macrothrombogenesi
figur
annot
bold
face
pathogenesi
occur
ulvwf
path
tf
path
combin
path
activ
depend
upon
level
damag
intravascular
injuri
endothelium
setevt
charact
microthrombi
fibrin
clot
macrothrombu
differ
path
differ
produc
distinctli
differ
clinic
thrombot
disord
b
three
path
thrombogenesi
base
twopath
unifi
theori
reproduc
updat
permiss
chang
tradit
accept
hemostasi
base
concept
primari
hemostasi
local
vascular
injuri
follow
secondari
hemostasi
form
fibrin
clot
howev
concept
explain
microthrombi
thrombu
format
therefor
novel
twopath
unifi
theori
hemostasi
deriv
vascular
physiolog
logic
hemostasi
base
hemostat
principl
essenti
compon
particip
hemostasi
known
work
mani
dedic
coagul
scientist
pleas
note
differ
thrombogenet
path
twopath
unifi
theori
macrothrombogenesi
microthrombogenesi
fibrinogenesi
annot
bold
face
thrombogenet
path
occur
ulvwf
path
tf
path
andor
combin
path
util
depend
upon
vascular
level
damag
intravascular
injuri
includ
endothelium
set
evt
charact
thrombusblood
clot
differ
path
uniqu
produc
distinctli
differ
clinic
thrombot
disord
pathogenesi
ard
via
microthrombogenesi
due
lone
activ
ulvwf
path
promot
microthrombi
string
made
plateletulvwf
complex
pulmonari
vasculatur
apl
indic
acut
promyelocyt
leukemia
dic
dissemin
intravascular
coagul
dvt
deep
vein
thrombosi
eavmtd
endotheliopathyassoci
vascular
microthrombot
diseas
evt
extravascular
tissu
set
subendotheli
tissu
tf
tissu
factor
ulvwf
unusu
larg
von
willebrand
factor
multim
associ
consumpt
coagulopathi
deplet
fviii
fv
instead
acut
dic
character
hepat
coagulopathi
markedli
increas
fviii
markedli
decreas
fvii
decreas
fii
fv
fix
fx
chronic
dic
character
thrombocytopenia
maha
mod
without
coagulopathi
ye
statement
true
pictur
ttplike
syndrom
dic
ttp
hu
ttplike
syndrom
thrombot
microangiopathi
similar
differ
diseas
instead
diseas
call
ttplike
syndrom
except
ttp
gavmtd
aavmtd
dic
respond
therapeut
agent
util
clinic
trial
reason
unexplain
ye
statement
true
reason
clinic
trial
design
base
incorrect
pathogenet
mechan
expect
respond
antimicrothrombot
therapi
hand
eavmtddit
occur
due
microthrombogenesi
result
lone
activ
ulvwf
path
hemostasi
statement
conclud
follow
dic
incorrect
concept
consist
eavmtddit
chronic
dic
incorrect
term
eavmtddit
without
hepat
coagulopathi
acut
dic
incorrect
term
consist
eavmtddit
hepat
coagulopathi
tradit
dic
includ
dic
associ
sepsi
trauma
critic
ill
true
dic
occur
acut
promyelocyt
leukemia
apl
rare
case
certain
snake
venom
bite
former
microthrombot
diseas
due
microthrombi
string
ttplike
syndrom
latter
hemorrhag
disord
due
fibrin
clot
fibrin
clot
diseas
sinc
dic
reapprais
ttplike
syndrom
ie
eavmtddit
move
dic
column
dit
leftov
true
dic
occur
apl
fibrin
clot
form
fibrinogenesi
via
extrins
coagul
cascad
activ
aberr
tf
path
final
sepsisassoci
coagulopathi
ie
microthrombopathi
seen
ard
readili
understood
eavmtd
dit
clinic
phenotyp
ttplike
syndrom
without
hepat
coagulopathi
hand
aplassoci
coagulopathi
via
fibrinogenesi
understood
true
dic
dissemin
fibrin
clot
diseas
brief
note
dic
dic
seem
complex
conceptu
issu
time
reader
comprehens
would
becom
simpl
clear
two
theori
figur
b
understood
help
figur
wonder
could
unmask
true
ident
dic
term
use
year
date
succinctli
speak
ard
organ
phenotyp
hemostat
diseas
occur
result
gener
endotheliopathi
ie
eavmtddit
lead
lone
activ
ulvwf
path
promot
microthrombot
pathway
ie
microthrombogenesi
orchestr
consumpt
thrombocytopenia
maha
mod
ttplike
syndrom
gener
endotheliopathi
also
activ
inflammatori
pathway
independ
microthrombot
pathway
pathophysiolog
mechan
involv
ard
summar
follow
complement
activ
ard
well
recogn
decad
howev
relationship
ard
complement
activ
explor
even
though
role
suspect
contribut
pathogenesi
highli
pathogen
viral
infect
also
implic
acut
lung
injuri
activ
complement
system
one
key
event
defens
mechan
sepsi
protect
function
host
rapidli
identifi
elimin
invad
pathogen
opson
foreign
surfac
coval
attach
fulfil
major
function
cell
clearanc
phagocytosi
amplif
complement
activ
format
surfacebound
convertas
assembl
convertas
cleavag
induc
format
multiprotein
pore
complex
ie
membran
attack
complex
mac
lead
cell
lysi
even
though
major
role
protect
function
host
innat
immun
defens
complement
activ
could
promot
destruct
action
innoc
bystand
endothelium
host
lead
endotheliopathi
neutrophil
extracellular
trap
netosi
may
impact
cours
sepsi
critic
ill
membran
attack
complex
exert
deleteri
effect
host
ec
unless
glycoprotein
adequ
express
ec
protect
inhibit
polymer
mac
downregul
due
either
gene
mutat
acquir
diseas
perhap
activ
complement
could
readili
exert
destruct
effect
host
ec
caus
endotheliopathi
critic
ill
mac
attack
membran
ec
channel
transmembran
pore
format
develop
endotheli
membran
trigger
endotheliopathi
consid
role
complement
ard
well
sepsi
endotheli
dysfunct
via
activ
complement
cascad
suspect
major
compon
contribut
patholog
hemostasi
ard
endotheliopathi
ard
activ
major
molecular
mechan
one
sever
inflamm
caus
inflammatori
cytokin
releas
endothelium
hypox
organ
dysfunct
caus
partial
hemostasi
via
microthrombogenesi
illustr
figur
endotheli
dysfunct
long
known
key
modul
pathogenesi
ard
well
sepsi
critic
ill
marker
variou
cytokin
coagul
particip
indic
endotheli
damag
significantli
alter
patient
critic
ill
compar
control
includ
vwf
fviii
endotheli
procoagul
recent
view
role
endotheliopathi
concept
vmtd
base
novel
vivo
twopath
unifi
theori
hemostasi
ard
pathogenesi
assur
result
patholog
hemostasi
ard
heterogen
express
cell
adhes
molecul
ec
also
note
human
pulmonari
vasculatur
although
eselectin
vascular
cell
adhes
molecul
express
ec
normal
lung
immunochem
studi
show
strong
express
molecul
larger
vessel
lung
support
induct
upregul
ard
perhap
adhes
molecul
could
play
secondari
role
endotheli
heterogen
netosi
phenotyp
ardsassoci
mod
confirm
ard
primari
diseas
caus
variou
organ
dysfunct
syndrom
secondari
syndrom
due
one
hypox
organ
dysfunct
result
microthrombosi
caus
endotheliopathi
like
mod
illustr
figur
concept
mod
promot
one
pathogenet
mechan
ie
microthrombogenesi
provok
gener
endotheliopathi
bespeak
follow
import
implic
understand
ard
mod
acut
respiratori
distress
syndrom
primari
diseas
secondari
clinic
syndrom
associ
one
differ
underli
caus
eg
sepsi
trauma
complic
pregnanc
surgeri
transplant
cancer
drugtoxin
autoimmun
diseas
other
ard
mod
occur
result
underli
pathophysiolog
mechan
identifi
microthrombogenesi
due
gener
endotheliopathi
lead
vmtd
ard
mod
phenotyp
eavmtddit
ard
mod
would
respond
treatment
base
pathophysiolog
mechan
certainli
conceptu
relationship
ard
mod
guid
us
better
understand
endotheli
molecular
pathogenesi
endothelium
distribut
entir
organ
system
tissu
human
bodi
protect
intern
diseas
extern
bodili
injuri
hemostasi
circulatori
homeostasi
endotheli
pathogenesi
vmtd
organ
phenotyp
express
variabl
among
differ
host
pathogen
toxin
well
differ
pathogen
toxin
variabl
express
turn
produc
unusu
exot
manifest
mod
phenotyp
like
develop
due
two
main
endow
biolog
mechan
endotheli
heterogen
host
organotrop
pathogen
toxin
variabl
clinic
organ
phenotyp
syndrom
occur
seen
type
pathogen
exampl
hanta
viru
caus
cardiopulmonari
syndrom
heart
lung
shiga
toxinproduc
escherichia
coli
present
encephalopathi
hu
brain
kidney
neisseria
meningitid
incit
waterhousefriderichsen
syndrom
mening
adren
mening
cours
organ
phenotyp
occur
due
differ
type
pathogen
one
interest
observ
ard
common
occurr
combin
syndrom
ard
acut
necrot
pancreat
charact
biorgan
attract
vmtd
particular
patient
similar
seen
combin
syndrom
hepat
encephalopathi
cardiopulmonari
syndrom
hepatoren
syndrom
pulmonaryren
syndrom
other
circulatori
dysfunct
patholog
find
diffus
alveolar
damag
ard
necrot
pancreat
damag
acut
pancreat
certainli
support
biorgan
syndrom
caus
pathogenet
mechan
associ
vascular
microthrombosi
endotheli
heterogen
andor
tropism
select
organ
local
microthrombi
vascular
microthrombosi
inflict
physic
damag
organ
clinic
practic
oversimplifi
design
organ
phenotyp
encephalopathi
rhabdomyolysi
well
ard
might
interf
detect
underli
etiolog
mechan
multiorgan
syndrom
well
vmtd
author
claim
one
organ
phenotyp
syndrom
ard
caus
sever
organ
dysfunct
includ
pancreat
encephalopathi
renal
failur
hepat
failur
howev
understood
ard
addit
organ
syndrom
begin
equal
foot
system
vmtd
sever
select
organ
damag
determin
local
select
endotheli
heterogen
tropism
sinc
ard
primari
diseas
term
extrapulmonari
manifest
extrapulmonari
phenotyp
ard
misrepresent
author
opinion
conceptu
misunderstand
contribut
delay
recogn
pathophysiolog
mechan
ard
well
mod
hu
fulmin
hepat
failur
acut
pancreat
biorgan
syndrom
other
although
ard
suspect
associ
pulmonari
vascular
microthrombosi
taken
sever
decad
recogn
microthrombosi
distinctli
differ
diseas
macrothrombosi
seen
dvt
pulmonari
embol
pe
even
though
ard
differ
dvt
pe
clinician
still
might
equat
charact
microthrombosi
ard
dvt
known
one
chang
mechan
thrombosi
blood
clot
due
activ
tffviia
path
time
accept
microthrombosi
ard
product
differ
hemostasi
macrothrombosi
dvt
pe
distinct
certainli
support
new
concept
mod
includ
encephalopathi
hu
acut
necrot
pancreat
diffus
myocardi
ischemia
fulmin
hepat
failur
dvt
pe
multiorgan
dysfunct
syndrom
caus
microthrombosi
ard
result
microthrombogenesi
term
microthrombogenesi
defin
previous
mention
two
hemostat
theori
theori
congruent
although
twoactiv
theori
endothelium
repres
endotheli
molecular
pathogenesi
follow
exocytosi
ulvwf
endotheliopathi
figur
twopath
unifi
theori
elabor
vivo
hemostat
process
follow
intravascular
injuri
via
releas
ulvwf
figur
essenc
microthrombogenesi
endotheli
molecular
pathogenesi
vivo
hemostasi
ident
former
expand
version
ulvwf
path
illustr
vmtd
orchestr
clinic
patholog
phenotyp
via
endotheliopathi
hemostasi
base
twopath
unifi
theori
ttp
ttplike
syndrom
character
dit
involv
vital
organ
true
dic
thrombot
microangiopathi
hu
ard
therefor
classifi
vmtd
discuss
earlier
reinterpret
dic
dic
disord
eavmtddit
hematolog
phenotyp
ttplike
syndrom
contemporari
theori
tffviiainiti
coagul
cascad
cellbas
coagul
theori
explain
microthrombi
string
compos
plateletulvwf
complex
fibrin
clot
within
intravascular
space
conceptu
conflict
activ
tf
path
activ
ulvwf
path
alert
author
insight
must
least
two
differ
path
hemostasi
exist
two
utterli
differ
charact
blood
clotsmicrothrombi
fibrin
clotshav
contribut
redraw
framework
two
differ
thrombogenet
mechan
microthrombogenesi
ulvwf
path
fibrinogenesi
tf
path
former
assembl
microthrombi
string
seen
vmtd
ttp
ttplike
syndrom
dic
hu
ard
latter
gener
fibrin
clot
seen
apl
certain
envenom
next
question
charact
dvt
arteri
thrombu
seen
aortic
aneurysm
sinc
neither
microthrombi
fibrin
clot
instead
obvious
macrothrombu
contain
fibrin
clot
platelet
therefor
conclud
ulvwf
path
tf
path
must
involv
format
macrothrombosi
dvt
arteri
thrombosi
elucid
twopath
unifi
theori
born
explain
twopath
unifi
theori
hemostasi
also
three
path
thrombogenesi
includ
microthrombogenesi
fibrinogenesi
macrothrombogenesi
figur
b
final
vivo
hemostat
mechan
includ
addit
role
netosi
unifi
stage
activ
ulvwf
path
activ
tf
path
indirectli
discov
present
hallmark
ard
vascular
microthrombosi
ie
vmtd
seen
sepsi
sepsi
character
gener
endotheliopathi
without
compromis
set
evt
also
ard
hemostat
involv
sepsi
lone
activ
ulvwf
path
ec
lead
format
microthrombi
bleed
develop
set
evt
damag
occur
tf
path
activ
unlik
local
macrothrombosi
eg
thrombu
aortic
aneurysm
acut
ischem
stroke
dvt
dissemin
microthrombosi
ie
dit
present
mani
intrigu
featur
ard
hu
well
varieti
hematolog
syndrom
includ
thrombocytopenia
maha
ttplike
syndrom
dic
accord
twopath
unifi
theori
hemostasi
two
thromboticcoagul
pathway
ulvwf
tf
path
initi
normal
hemostasi
later
two
path
must
unifi
conclud
normal
hemostasi
passiv
role
net
hemostasi
stop
bleed
extern
bodili
injuri
produc
thrombosi
intravascular
injuri
differ
level
depth
intravascular
injuri
present
tabl
differ
path
thrombogenesi
take
place
depend
upon
compon
vascular
wall
damag
figur
intravascular
damag
confin
ec
level
lone
ulvwf
path
becom
activ
caus
microthrombosi
ie
vmtd
tia
ttplike
syndrom
ard
mod
tf
path
activ
hand
intravascular
damag
extend
ec
set
level
ulvwf
path
tf
path
becom
activ
caus
macrothrombosi
eg
dvt
acut
ischem
stroke
illustr
hemostat
theori
figur
b
addit
damag
extend
ec
beyond
vessel
wall
includ
set
evt
level
ulvwf
path
tf
path
becom
activ
form
macrothrombosi
addit
evt
bleed
eg
thrombohemorrhag
stroke
summar
tabl
exampl
stroke
concept
import
understand
thrombogenesi
make
diagnosi
also
plan
treatment
also
anoth
situat
ec
setand
evt
damag
obtus
extern
trauma
bleed
occur
evt
smaller
vessel
without
bleed
damag
vascular
lumen
tissu
factor
releas
mix
blood
evt
activ
fvii
trigger
activ
tfvii
path
caus
hematoma
without
significantli
breach
ec
ulvwf
path
activ
logic
base
twopath
unifi
theori
pleas
see
figur
show
three
differ
thrombogenet
process
microthrombogenesi
fibrinogenesi
macrothrombogenesi
annot
boldshad
face
thrombogenesi
occur
ulvwf
path
tf
path
combin
path
activ
depend
upon
level
depth
damag
intravascular
injuri
charact
microthrombi
fibrin
clot
macrothrombu
differ
path
differ
produc
distinctli
differ
clinic
thrombot
disord
among
charact
ard
hemostat
diseas
made
microthrombi
string
molecular
pathogenesi
base
twoactiv
theori
endothelium
endotheli
molecular
pathogenesi
trigger
inflamm
well
known
document
medic
literatur
molecular
pathogenesi
promot
microthrombogenesi
understood
recent
although
underli
patholog
ard
vmtd
pathophysiolog
mechan
endotheliopathi
caus
vmtd
remain
mysteri
reason
progress
made
treatment
ard
comprehens
pathogenesi
microthrombosi
orchestr
hematolog
express
includ
thrombocytopenia
maha
mod
ttplike
syndrom
sinc
sepsi
initi
caus
microthrombosi
ard
manifest
organ
phenotyp
microthrombosi
sepsi
ard
often
coexist
thrombocytopenia
maha
mod
ttplike
syndrom
sir
may
occur
simultan
sepsi
ard
twoactiv
theori
endothelium
succinctli
explain
pathogenesi
eavmtddit
identifi
dit
diseas
promot
clinic
hematolog
syndrom
propos
thesi
endotheli
molecular
pathogenesi
ard
endotheliopathi
initi
two
import
molecular
event
releas
inflammatori
cytokin
eg
interleukin
il
tumor
necrosi
factor
adhes
molecul
other
activ
platelet
exocytosi
ulvwf
former
trigger
inflamm
process
call
activ
inflammatori
pathway
latter
mediat
microthrombogenesi
trigger
activ
microthrombot
pathway
two
independ
pathway
essenc
twoactiv
theori
endothelium
manifest
activ
inflammatori
pathway
fever
myalgia
arthralgia
malais
activ
microthrombot
pathway
produc
microthrombi
string
compos
plateletulvwf
complex
lead
vmtd
activ
endotheli
inflammatori
pathway
occur
due
cytokin
septic
nonsept
critic
ill
sepsisassoci
ard
inflamm
accentu
perhap
addit
loop
activ
circul
immun
cell
pathway
eg
macrophag
monocyt
neutrophil
lymphocyt
interact
activ
ec
pathway
upregul
express
inflammatori
respons
sometim
caus
cytokin
storm
addit
mechan
may
explain
sever
inflamm
occur
sepsi
trauma
hand
activ
microthrombot
pathway
promot
excess
exocytos
ulvwf
injur
ec
follow
endotheli
releas
ulvwf
becom
anchor
injur
ec
long
elong
string
addit
excess
ulvwf
proteas
cleav
ulvwf
smaller
molecular
weight
vwf
underexpress
due
addit
underli
heterozyg
gene
mutat
like
promot
eavmtddit
endotheli
molecular
pathogenesi
activ
inflammatori
pathway
microthrombot
pathway
clearli
explain
everi
hematolog
featur
organ
phenotyp
syndrom
occur
ard
past
sever
decad
mani
propos
redefinit
ard
forward
identifi
pathophysiolog
mechan
improv
outcom
diseas
better
classif
therapeut
design
howev
medic
commun
task
find
answer
pathogenesi
ard
far
recognit
ard
express
hemostat
diseas
character
vmtd
wide
open
door
understand
lifethr
phenotyp
organ
syndrom
also
redefin
clinic
mod
addit
identif
differ
thrombogenet
mechan
microthrombosi
fibrin
clot
diseas
macrothrombosi
variou
thrombot
disord
could
precis
defin
submechan
vivo
hemostasi
acut
respiratori
distress
syndrom
promin
organ
phenotyp
syndrom
develop
sepsi
critic
ill
among
mod
thu
understand
ard
organ
phenotyp
syndrom
lung
vmtd
abl
understand
organ
syndrom
due
vmtd
occur
brain
heart
liver
pancrea
muscl
adren
other
also
affirm
gener
eavmtddit
underli
diseas
ard
organ
syndrom
manifest
specif
organ
phenotyp
eavmtddit
make
matter
simpler
diagnost
evalu
therapeut
approach
everi
phenotyp
mod
final
abl
treat
patient
everi
organ
phenotyp
syndrom
combin
biorgan
syndrom
mod
due
eavmtddit
regimen
focus
microthrombogenesi
tabl
summar
ident
ard
defin
clinic
etiolog
pathogenet
phenotyp
featur
eavmtd
pulmonari
physiolog
alter
hypoxemia
increas
capillari
permeabl
circulatori
failur
patholog
chang
diffus
alveolar
damag
exud
pulmonari
edema
hyalin
membran
format
result
pulmonari
vascular
microthrombosi
thu
therapi
ard
directli
target
pathogenesi
produc
vmtd
berlin
definit
ard
address
limit
americaneuropean
consensu
confer
definit
poor
reliabl
criteria
may
contribut
underrecognit
antipathi
clinician
pharmacolog
treatment
aim
underli
patholog
shown
effect
date
manag
remain
support
lungprotect
mechan
ventil
addit
cardiopulmonari
evalu
physiolog
chang
due
respiratori
distress
well
assess
underli
diseas
proper
diagnost
approach
ard
start
hematolog
evalu
first
everi
patient
ard
evalu
potenti
unrecogn
ttplike
syndrom
previous
defin
dic
unexplain
thrombocytopenia
exclus
known
caus
thrombocytopenia
initi
clue
suggest
ongo
microthrombogenesi
lead
eavmtddit
addit
find
maha
even
minim
degre
schistocytosi
present
confirm
diagnosi
ttplike
syndrom
look
schistocyt
evid
hemolysi
blood
film
examin
daili
sever
consecut
day
experienc
hematologist
unlik
antibodyassoci
ttp
aavmtd
acquir
ttp
schistocyt
fewer
ard
perhap
due
differ
forc
shear
stress
pulmonari
vasculatur
critic
care
set
past
hemostat
natur
could
miss
due
inattent
blood
film
low
index
suspicion
even
though
evalu
unexplain
thrombocytopenia
anemia
could
attempt
ard
thrombocytopenia
intravascular
hemolysi
ie
anemia
reticulocytosi
increas
lactic
acid
dehydrogenas
indirect
hyperbilirubinemia
hypohaptoglobinemia
neg
coomb
test
might
suffici
criteria
establish
diagnosi
ttplike
syndrom
begin
lifesav
tpe
earliest
possibl
time
solidifi
concept
underli
patholog
ard
eavmtddic
author
recommend
determin
activ
autoantibodi
statu
gene
mutat
studi
fibrinogen
quantit
fviii
vwf
activ
circul
coagul
factor
assay
liverdepend
factor
ie
fii
fv
fvii
fix
fx
determin
caus
coagulopathi
ie
hepat
coagulopathi
diagnost
assess
summar
tabl
sinc
ard
one
mod
clinician
stay
vigil
close
clinic
monitor
develop
addit
organ
phenotyp
mod
illustr
figur
reflect
past
clinic
trial
half
centuri
sinc
term
ard
coin
extens
control
clinic
trial
conduct
ard
evalu
effect
pharmaceut
agent
statin
agonist
antiinflammatori
agent
corticosteroid
nutrit
supplement
glutamin
selenium
fatti
acid
antioxid
therapi
nacetyl
cystein
prevent
treatment
unfortun
trial
fail
significantli
benefit
patient
ard
fact
pathophysiolog
mechan
ard
clearli
recogn
failur
therapeut
regimen
restor
physiolog
alter
ard
endotheliopathi
certainli
indic
pathogenesi
ard
yet
discov
author
confid
novel
hemostat
twopath
unifi
theori
twoactiv
theori
endothelium
uncov
long
hidden
mysteri
pathogenesi
ard
yield
effect
therapeut
regimen
sooner
later
therapeut
plasma
exchang
addit
best
support
care
proper
antibiot
ventil
support
appropri
fluid
electrolyt
balanc
ard
obviou
therapeut
approach
target
pathogenesi
sinc
newli
recogn
concept
pathogenesi
hemostat
diseas
call
pulmonari
vascular
microthrombosi
ie
ttplike
syndrom
result
eavmtddit
caus
lone
activ
ulvwf
path
therapeut
design
util
inhibit
vascular
microthrombogenesi
present
avail
antimicrothrombot
regimen
tpe
rational
microthrombosi
produc
excess
product
ulvwf
endotheliopathi
rel
insuffici
perhap
due
unsuspect
gene
mutat
respond
addit
suppli
ulvwfcleav
exchang
normal
donor
plasma
inde
ttplike
syndrom
associ
ard
shown
excel
respons
tpe
employ
earli
stage
sinc
lung
organ
respons
oxygen
suppli
organ
ard
import
organ
phenotyp
among
mod
could
hasten
demis
patient
due
sever
hypoxemia
time
earliest
intervent
util
tpe
potenti
effect
treatment
save
live
otherwis
patient
entrench
mechan
ventil
volum
overload
follow
intraven
fluid
blood
transfus
recoveri
ard
may
becom
remot
even
tpe
sepsi
septic
shock
tpe
use
sporad
ard
even
without
understand
concept
microthrombogenesi
vmtd
shown
signific
benefit
safeti
case
report
limit
clinic
seri
antimicrothrombot
therapi
ttp
ttp
syndrom
includ
dic
shown
benefici
effect
tpe
surrog
replac
therapi
despit
technic
limit
inconveni
theoret
effici
therapeut
regimen
would
antimicrothrombot
agent
could
includ
recombin
possibl
nacetyl
cystein
agent
neither
approv
util
human
use
defin
antimicrothrombot
agent
although
clinic
trial
gavmtd
prove
benefit
ard
therapeut
potenti
save
mani
live
patient
eavmtddit
critic
care
medicin
would
immeasur
worsen
thrombocytopenia
ie
tcip
import
laboratori
sign
suggest
progress
ard
situat
platelet
transfus
might
tempt
contraind
eavmtddic
platelet
transfus
would
promot
microthrombogenesi
intensifi
mod
associ
dit
well
maha
also
may
provok
trali
syndrom
hepat
coagulopathi
coexist
ard
coagulopathi
could
rapidli
progress
combin
microthrombohemorrhag
syndrom
demand
special
care
coordin
coagul
specialist
last
pathogenesi
ard
identifi
hemostat
diseas
occur
due
lone
activ
ulvwf
path
hemostasi
result
endotheliopathi
critic
ill
patient
underli
patholog
eavmtddit
clinic
phenotyp
ttplike
syndrom
gener
endotheliopathi
activ
inflammatori
pathway
microthrombot
pathway
trigger
eaditvmtd
former
provok
inflamm
latter
promot
consumpt
thrombocytopenia
ttplike
syndrom
hypox
mod
system
inflammatori
respons
syndrom
combin
syndrom
two
independ
activ
endotheli
molecular
pathogenes
acut
respiratori
distress
syndrom
pulmonari
organ
phenotyp
among
variou
ttplike
syndrom
acut
respiratori
distress
syndrom
respond
tpe
initi
earli
stage
disord
potenti
effect
target
therapeut
strategi
explor
antimicrothrombot
agent
earliest
possibl
time
save
live
author
express
sincer
appreci
miss
emma
nichol
zebrowski
insight
structur
function
blood
vessel
wall
vivo
hemostasi
excel
illustr
art
work
figur
author
declar
potenti
conflict
interest
respect
research
authorship
andor
public
articl
author
receiv
financi
support
research
authorship
andor
public
articl
orcid
id
jae
c
chang
http
